Companies · Software / Tech
ALLENDALE · Software / Tech · refined from filed group “Other Health Care”
Diligence memoA one-page analyst read on Acuitive Technologies, Inc. — recommendation, valuation, rhythm, risks.→Acuitive Technologies, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Acuitive Technologies, Inc. is one of 3920 Software / Tech companies tracked from ALLENDALE. By capital raised it ranks in the upper tier (ahead of 81% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 81% of sector peers (real $). Modeled value above 69% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #71 of 413.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Solidblock Holdings LLC Detox Digital Series | Series A | $15.0M | $210.2M | 4.16× |
| inFeedo Tech Inc. | Series A | $14.3M | $205.9M | 4.08× |
| Red Leader Technologies, Inc. | Series A | $13.8M | $202.0M | 4.00× |
| Mocha Technologies Inc. | Series A | $13.4M | $200.7M | 3.98× |
| Isometric Technologies Inc. | Series A | $15.0M | $193.3M | 3.83× |
| Carbon6 Technologies, Inc. | Series A | $15.9M | $188.0M | 3.72× |
| Grin Technology Services, Inc. | Series A | $14.7M | $180.7M | 3.58× |
| Nucleated Foam Technologies, Inc. | Series A | $12.5M | $174.2M | 3.45× |
| Primer Labs Inc. | Series A | $12.9M | $169.4M | 3.36× |
| Triumph Labs, Inc. | Series A | $12.1M | $165.0M | 3.27× |
| Thred Technologies, Inc. | Series A | $14.9M | $160.1M | 3.17× |
| MetaStreet Labs, Inc. | Series A | $26.2M | $157.4M | 3.12× |
| Acuitive Technologies, Inc. this company | Series A | $22.5M | $90.2M | 1.79× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $3.8M | 2021-05-10 | $19.1M | $86.5M | 90% |
| Pre-Seed | $855K | 2021-05-10 | $4.8M | $22.7M | 90% |
| Series A | $5.8M | 2022-07-28 | $26.2M | $69.0M | 90% |
| Series A | $13.0M | 2023-12-01 | $58.9M | $90.2M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Alex Khowaylo | — | 2 other | 2021-05 |
| David S. Washburn | — | 2 other | 2021-05 |
| Michael P. McCarthy | — | 2 other | 2021-05 |
| Alex S. Khowaylo | — | — | 2023-12 |
| Gary S. Fischetti | — | — | 2023-12 |
| James S. Maylayter | — | — | 2023-12 |
| Michael S. McCarthy | — | — | 2023-12 |
| Vincent S. Forlenza | — | — | 2023-12 |
Acuitive Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Pipeline Biomedical, Inc. | Biotechnology | Series A | $8.0M | $289.2M | network3 shared operators · same stage |
| Pipeline Biomedical Holdings, Inc. | Biotechnology | Seed | $3.2M | $142.1M | network3 shared operators |
| Uneven Labs, Inc. | Software / Tech | Series A | $22.8M | $68.0M | same sector · same stage |
| Minesense Technologies Ltd. | Software / Tech | Series A | $23.3M | $87.4M | same sector · same stage |
| Vital Labs, Inc. | Software / Tech | Series A | $23.7M | $83.5M | same sector · same stage |
| Tracer Labs, Inc. | Software / Tech | Series A | $20.9M | $87.8M | same sector · same stage |
| Candor Technology, Inc. | Software / Tech | Series A | $24.4M | $110.8M | same sector · same stage |
| Mira Labs, Inc. | Software / Tech | Series A | $20.6M | $70.8M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Accuity Delivery Systems, LLC | Software / Tech | Series B | $776.6M | 85% |
| Holisticly Technologies, Inc. | Software / Tech | Pre-Seed | $1.7M | 85% |
| Surgicure Technologies, Inc. | Software / Tech | Seed | $11.0M | 84% |
| InterShunt Technologies, Inc. | Software / Tech | Series B | $168.5M | 84% |
| SensaSure Technologies, Inc. | Software / Tech | Pre-Seed | $6.1M | 84% |
| Acutus Medical, Inc. | Healthtech | Series D+ | $68.9M | 84% |
| Alden Advanced Technologies, Inc. | Software / Tech | Seed | $9.9M | 83% |
| Medici Technologies, LLC | Software / Tech | Series B | $618.0M | 83% |
See where Acuitive Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Acuitive Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.